Our results demonstrate that, for both CRC and ADA prediction, the Wilcoxon rank-sum test and MetagenomeSeq outperform the baseline across both 16S and WGS datasets [Figure 4A and B]. The gene discussed is ADA; the disease is colorectal carcinoma.